Orcinol Glucoside Facilitates the Shift of MSC Fate to Osteoblast and Prevents Adipogenesis via Wnt/β-Catenin Signaling Pathway [Retraction]

Orcinol Glucoside Facilitates the Shift of MSC Fate to Osteoblast and Prevents Adipogenesis via Wnt/β-Catenin Signaling Pathway [Retraction]

Zhou X, Liu Z, Huang B, et al. Drug Des Devel Ther. 2019;13:2703–2713. The Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of Oil Red O images in Figures 4 and Figure 6. Specifically...

Full description

Bibliographic Details
Main Authors: Zhou X, Liu Z, Huang B, Yan H, Yang C, Li Q, Jin D
Format: Article
Language:English
Published: Dove Medical Press 2023-03-01
Series:Drug Design, Development and Therapy
Subjects:
orcinol glucoside
osteoporosis
mesenchymal stem cell
osteoblast
cell differentiation.
Online Access:https://www.dovepress.com/retraction-orcinol-glucoside-facilitates-the-shift-of-msc-fate-to-oste-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/retraction-orcinol-glucoside-facilitates-the-shift-of-msc-fate-to-oste-peer-reviewed-fulltext-article-DDDT

Similar Items